false
OasisLMS
Catalog
New Diagnostics and Guidelines Developments Advanc ...
New Diagnosis and Guideline Updates for Hepatitis ...
New Diagnosis and Guideline Updates for Hepatitis C Elimination in the US
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Eduardo Gepez-Guevara and colleagues discuss advancements in eliminating hepatitis C (HCV) in the United States, featuring a presentation by Dr. Caroline Wester from the CDC. Despite the curability of HCV, approximately 2.4 million Americans are affected, with many unaware of their status. While progress has been made in reducing HCV-related deaths, new infection rates remain high. Updated screening guidelines recommend universal one-time screening for adults, including pregnant women, to address gaps left by risk-based testing. Barriers such as limited access to testing and treatment, especially for high-risk populations, impede elimination efforts. The introduction of a point-of-care RNA test by the FDA offers potential for streamlined diagnosis and immediate treatment initiation. Ensuring affordable testing, high-level political support, and integrated care in high-risk settings are essential steps learned from global collaborations. The full presentation is available on liver learning.
Keywords
Hepatitis C
screening guidelines
point-of-care RNA test
barriers to treatment
integrated care
×
Please select your language
1
English